Kazakhstan is the largest country in Central Asia with a population of 18.5 million. It strategically links the markets of China and South Asia with those of Russia and the European Union. The country has shown impressive economic growth in the last decade and is an emerging location for international clinical trials.
As well as occupying a geostrategic position in relation to markets to the East and West, Kazakhstan’s membership of Eurasian Economic Union (EAEU) allows for simplified logistics across the CIS region. In addition, recent harmonization of legislation regarding clinical trials has expediated start-up timelines for studies.
“Our decision to strengthen our presence in Kazakhstan is in response to the growing needs of international sponsors in high recruiting countries. We look forward to introducing international sponsors to this market and supporting the smooth operation of their clinical studies,” said Andrey Tarakanov, CEO at COREX Logistics.
COREX Logistics is a full-cycle provider of clinical trials supply and logistics solutions since 2011. It is a leading provider of support services for drug development and clinical research across the CIS and Eastern Europe with its international HQ in Dublin, Ireland.
For more information on the advantages of conducting clinical research in Kazakhstan visit: www.corex-logistics.com
About COREX Logistics
COREX Logistics is a full-cycle provider of clinical trials supply and logistics solutions since 2011. It is a leading provider of support services for drug development and clinical research across the CIS and Eastern Europe with its international HQ in Dublin, Ireland. Visit www.corex-depot.com for more.